Localized pemphigus herpetiformis: two case ... - Dermatologica Sinica

15 downloads 0 Views 881KB Size Report
Jul 6, 2009 - Pemphigus herpetiformis (PHF) is a rare variant of pemphigus that combines ... cal features of dermatitis herpetiformis and immunopathological ...
DERMATOLOGICA SINICA 28 (2010) 36–39

CAS E REP O RT

Localized pemphigus herpetiformis: two case reports Cheng-Chieh Huang1, Yu-Hung Wu1,2*, Chi-Fu Kao1 1

Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan Mackay Medicine, Nursing and Management College, Taipei, Taiwan

2

KEY WO R D S

A B S T R AC T

Localized Pemphigus herpetiformis Pustules

Pemphigus herpetiformis (PHF) is a rare variant of pemphigus that combines the clinical features of dermatitis herpetiformis and immunopathological features of pemphigus. In previous case reports, distribution of lesions is usually generalized, involving trunk and limbs. We report two cases of localized PHF presenting with grouped pustules on bilateral dorsal feet and left preauricular area, respectively. Microscopic examination showed neutrophilic spongiosis, subcorneal pustules, and focal acantholysis. Both direct immunofluorescence of Case 1 and indirect immunofluorescence of Case 2 revealed moderate deposition of IgG in the intercellular space of upper epidermis. Based on the typical histologic features and immunopathological findings, diagnoses of PHF were made. However, the atypical and localized clinical presentation rendered the process of reaching a diagnosis more difficult. PHF should be added in the spectrum of differential diagnosis of localized pustular disorders. Copyright © 2010, Taiwanese Dermatological Association. Published by Elsevier Taiwan LLC. All rights reserved.

Introduction

Case reports

Pemphigus herpetiformis (PHF) is a rare variant of pemphigus that combines the clinical features of dermatitis herpetiformis and immunopathological features of pemphigus. Many synonyms (dermatitis herpetiformis with acantholysis, sulfonamide-responsive pemphigus, mixed bullous disease) were used up till 1975 when the term “pemphigus herpetiformis” was coined by Jablonska et al.1 Since then, several case reports in the literature have described the clinical variety of PHF.2–8 We report two atypical cases of localized form of PHF. Common to previous case reports is a clinical presentation of wide-spread distribution of lesions, usually involving both the trunk and limbs.

Case 1

*Corresponding author. Department of Dermatology, Machay Memorial Hospital, 92 Zhongshan Road North, Section 2, Zhongshan District, Taipei 10449, Taiwan. E-mail: [email protected] Received: Jan 7, 2009 ● Revised: Jul 6, 2009 ● Accepted: Jul 8, 2009

An 80-year-old man with a 6-year history of prostate cancer and who was under regular hormonal therapy came to our clinic due to progressively itchy and painful skin lesions (which had lasted for weeks). Physical examination showed erythematous patches with desquamation and multiple pustules on bilateral dorsal feet (Figure 1A). Examination with 10% potassium hydroxide revealed no fungal hyphae or spores. Histopathological examination showed spongiosis and subcorneal pustules composed of many neutrophils and eosinophils (Figure 1B). Focal acantholytic keratinocytes were also observed under higher magnification (Figure 1C). Direct immunofluorescence showed moderate deposition of immunoglobulin (Ig) G and complement 3 in the intercellular space of the upper epidermis (Figure 1D). Immunofluorescence for IgA, IgM, and fibrinogen were negative. Diagnosis of PHF was made according to the distinct clinical features

37

Localized pemphigus herpetiformis

A

B

C

D

Figure 1 (A) Erythematous patches on bilateral dorsal feet with many pustules and desquamation. (B) Subcorneal pustule with numerous neutrophils and eosinophils (H&E, 100×). (C) Acantholytic keratinocytes can be seen in subcorneal pustule (H&E, 400×). (D) Direct immunofluorescence shows IgG deposition over the intercellular space of upper epidermis (400×).

and pathological findings. Low dose systemic steroid prednisolone (20 mg/day) was given and clinical response was good. The pustules subsided rapidly after 2 weeks of therapy. We tapered off systemic steroid a month and a half later; no recurrence was noted at subsequent follow-ups. Unfortunately, the patient’s prostate cancer progressed with multiple bone metastases a year after the initial diagnosis of PH. The patient died in 2 years; there was no skin lesion recurrence during this period.

Case 2 A 55-year-old woman without significant past medical history presented with itchy skin lesions for several months. Physical examination showed grouped herpetiform pustules on erythematous patches over left preauricular area (Figure 2A). Tzanck smear and microscopic examination with 10% potassium hydroxide of the lesions on left preauricular area were negative. Histopathological examination of skin biopsy specimen from preauricular lesions showed subcorneal pustules and focal acantholysis (Figures 2B and 2C). The differential

diagnoses included dermatophytosis, superficial pemphigus and subcorneal pustular dermatoses. Direct immunofluorescence was not performed because autoimmune bullous disease was not clinically suspected initially. Indirect immunofluorescence from patient’s serum using monkey esophagus as substrate was arranged and revealed moderate deposition of IgG over the intercellular space of the epidermis (Figure 2D). Although indirect immunofluorescence for IgA was not performed, PHF was diagnosed according to strong IgG intercellular deposition and superficial subcorneal acantholysis. She received treatment with oral antihistamine and topical steroid for preauricular lesions. The clinical condition improved 2 weeks after treatment and was without recurrence in the 2-year follow-up period.

Discussion The clinical distribution of PHF, in the few case reports is almost invariably generalized. The characteristic skin manifestations of PHF are pruritic erythematous vesicular, bullous,

38

C.C. Huang et al

A

B

C

D

Figure 2 (A) Erythematous papules and patches with pustules over left preauricular area. (B) Subcorneal pustule with accumulation of neutrophils (H&E, 100×). (C) Focal acantholysis can be seen (H&E, 400×). (D) Indirect immunofluorescense shows IgG deposition over intercellular spaces of the entire epidermis (100×).

or papular lesions in herpetiform pattern involving both the trunk and limbs, similar to those of dermatitis herpetiformis.9 Rare clinical presentations include measles-like lesions or urticarial plaques.2 Presence of pustules in PHF has been reported before, but the distribution was much wider (abdomen, back, leg, forearm, wrist).10 Localized PHF was atypical and rare, which made the clinical diagnosis of pemphigus more difficult. The differential clinical diagnoses in our cases might have included herpes infection, dermatophytosis, contact dermatitis with secondary bacterial infection or other rare bullous disorders, such as subcorneal pustular dermatosis and IgA pemphigus. The strong deposition of IgG and absence of IgA immunofluorescence excluded the possibility of IgA pemphigus. Pemphigus was not suspected in Case 2; as a result, immunofluorescence examination was not ordered at first. Later on, positive results from indirect immunofluorescence performed allowed us to reach the final diagnosis. A previous study4 reported that less than half of patients with PHF had a positive indirect immunofluorescence. For physicians, this highlights the importance of recognizing the clinical features of localized

immunobullous disease for making appropriate investigations including skin biopsy and direct immunofluorescence examination. The histolopathological findings in PHF are characterized by intraepidermal blisters or subcorneal pustules, but not prominent acantholysis. These features make the histological diagnosis more difficult because similar findings are also present in pustular psoriasis, subcorneal pustular dermatosis, bullous impetigo, acute generalized exanthematous pustulosis, subcorneal pustular dermatosis-type IgA pemphigus and dermatophytosis. All these clinical entities have neutrophil exocytosis in the spongiotic epidermis with variable eosinophils in the infiltrate.4,7,10 A careful comparison of the clinical presentation and immunofluorescence staining of each case are necessary for correct diagnosis. Moreover, the intraepidermal neutrophilic infiltrate and intercellular IgG deposition can be present in cases of pemphigus foliaceus;11,12 this should not result in diagnostic problems however, due to the completely different clinical presentation of pemphigus foliaceus. Localized pemphigus vulgaris (PV) has been reported previously,13,14 and its presentation can be very similar to

39

Localized pemphigus herpetiformis

the current cases. Differenting between these two entities however, may rely on (1) more pustules in patients with PHF while erosions and crusts in those with PV; (2) histologically subcorneal and intraepidermal acantholysis in patients with PHF while suprabasal acantholysis in those with PV; (3) serologically, mainly anti-desmoglein-1 autoantibodies in patients with PHF while mainly anti-desmoglein-3 autoantibodies in those with PV. Neither Immunoblot nor ELISA was performed in our cases due to patients’ inactive status shortly after treatment. PHF was rarely associated with malignancies, although links with some cancers such as prostate cancer have been noted.15–17 The skin lesions in Case 1 were clinically irrelevant to his prostate cancer status however, and should therefore not be considered a paraneoplastic process. In conclusion, PHF does not always assume a generalized presentation. When it is localized, the clinical and histopathological diagnosis can be very difficult; making the correct diagnosis therefore relies on a positive immunofluorescence result. Thus, when approaching presentations of localized clusters of vesicles or pustules, one should always bear in mind the possibility of such a differential diagnosis.

References

3.

4. 5. 6. 7.

8. 9. 10. 11.

12. 13.

14.

15. 16.

1.

2.

Jablonska S, Chorzelski TP, Beutner EH, et al. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 1975; 14:353–9. Parodi A, Nunzi E, Rebora A. Urticaria as presenting manifestation of pemphigus herpetiformis. Dermatologica 1982;164:278–83.

17.

Ingber A, Feuerman EJ. Pemphigus with characteristics of dermatitis herpetiformis. A long-term follow-up of five patients. Int J Dermatol 1986;25:575–9. Maciejowska E, Jablonska S, Chorzelski T. Is pemphigus herpetiformis an entity? Int J Dermatol 1987;26:571–7. El Sherif AI, Bharija SC, Belhaj MS, et al. Pemphigus herpetiformis. Int J Dermatol 1990;29:737–8. Jablonska S, Chorzelski T. Pemphigus herpetiformis. Int J Dermatol 1992;31:144. [Comment] Santi CG, Maruta CW, Aoki V, et al; and Cooperative Group on Fogo Selvagem Research. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. J Am Acad Dermatol 1996;34:40–6. Dias M, dos Santos AP, Sousa J, et al. Herpetiform pemphigus. J Eur Acad Dermatol Venereol 1999;12:82–5. Robinson ND, Hashimoto T, Amagai M, Chan LS. The new pemphigus variants. J Am Acad Dermatol 1999;40:649–71. Huhn KM, Tron VA, Nguyen N, et al. Neutrophilic spongiosis in pemphigus herpetiformis. J Cutan Pathol 1996;23:264–9. Kouskoukis CE, Ackerman AB. What histologic finding distinguishes superficial pemphigus and bullous impetigo? Am J Dermatopathol 1984;6:179–81. Hoss DM, Shea CR, Grant-Kels JM. Neutrophilic spongiosis in pemphigus. Arch Dermatol 1996;132:315–8. Singal A, Pandhi D. Localized pemphigus vulgaris on cheeks responding to topical steroids. Indian J Dermatol Venereol Leprol 2009;75:80–1. Baykal C, Azizlerli G, Thoma-Uszynski S, Hertl M. Pemphigus vulgaris localized to the nose and cheeks. J Am Acad Dermatol 2002;47:875–80. Kubota Y, Yoshino Y, Mizoguchi M. A case of herpetiform pemphigus associated with lung cancer. J Dermatol 1994;21:609–11. Palleschi GM, Giomi B. Herpetiformis pemphigus and lung carcinoma: a case of paraneoplastic pemphigus. Acta Derm Venereol 2002;82:304–5. Marzano AV, Tourlaki A, Cozzani E, et al. Pemphigus herpetiformis associated with prostate cancer. J Eur Acad Dermatol Venereol 2007;21:696–8.